New research suggests that decreased activity of ELOVL2 -- a key enzyme in lipid metabolism -- accelerates white blood cell aging and alters genes associated with the onset of blood cancers.

New research finds reduced ELOVL2 enzyme activity speeds up immune cell aging and disrupts genes linked to cancer.